Addiction & Substance Use

What does the movie Dune say about our society’s current relationship with psychedelics?

What is vaping and when does it become a problem?

Chronic adolescent exposure to THC and cannabis could lead to adverse mental health outcomes and impacted brain functioning.

How can psychiatrists improve substance use treatment for Black and pediatric patients?

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

The American Medical Association is urging policymakers to act now to prevent further opioid overdose deaths.

Understanding addiction through new, creative lenses can offer a fresh perspective.

A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.

A recent survey found 70% of Afghanistan veterans have struggled with their mental health since serving.

Treating patients who may be perceived as “unlikeable” can be difficult.

As the seasons change and new possibilities open up, we also pause to remember the victims of September 11 and the ongoing opioid crisis.

Are benzodiazepine prescriptions contributing to the opioid overdose epidemic?

In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?

A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.

10 keys to understanding the science of cannabinoids.

Manufactured fentanyl is a major cause of overdoses for opioids and nonopiods. Can a vaccine immunize against overdose?

After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.

Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.

The potential role of eye movement desensitization and reprocessing.

Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?

To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.

Yes, we need better crisis management, but what we really need is better crisis prevention.

The enduring racial gap in the opiate addiction rate stems largely from racist 19th-century medical beliefs about Black bodies, coupled with substandard medical care provided to Black Civil War troops.

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.

How can understanding the opioid crisis in Canada inform strategies in the United States?

Healthy lungs are at risk—what can you do as a clinician to help patients quit vaping?